Clinical Trials Browser

Phase 2 × Hematologic Neoplasms × treosulfan × Clear all

NCT00129155 2007-10-04

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Phase 2 Unknown

Other hematologic neoplasm

Hematologic Neoplasms